Tapewire

NYSE · USD

G

Genpact LTD

Export transactions ↓
Tapewire entity
3760
SEC CIK
0001398659
Parsed reports
457

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202602
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202606
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 14, 2025 Filed Nov 17, 2025 22:26 UTC
Weiner Michael HalChief Financial Officer
SaleCommon Shares 13,365 $44.84 $599,286.60
Disclosure

SEC source: 0001591621-25-000004 · wk-form4_1763418370.xml · nonDerivative · entry 1

Weiner Michael Hal · CIK 0001591621 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,026

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.81 to $44.89. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2 · balance_after: Includes 169 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 1,358 shares under the ESPP.

Read SEC document
November 13, 2025 Filed Nov 13, 2025 22:01 UTC
White HeatherSVP & Chief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 45,703 $0.00 Strike: $27.70 $0.00
Disclosure

SEC source: 0001736502-25-000005 · wk-form4_1763071283.xml · derivative · entry 7

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 45,703 shares

Expires 2029-01-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested 50% on January 10, 2022 and 50% on January 10, 2024.

Read SEC document
November 13, 2025 Filed Nov 13, 2025 22:01 UTC
White HeatherSVP & Chief Legal Officer
SaleCommon Shares 45,703 $45.74 $2,090,455.22
Disclosure

SEC source: 0001736502-25-000005 · wk-form4_1763071283.xml · nonDerivative · entry 5

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,569

Read SEC document
November 13, 2025 Filed Nov 13, 2025 22:01 UTC
White HeatherSVP & Chief Legal Officer
Exercise / conversionCommon Shares 45,703 $27.70 $1,265,973.10
Disclosure

SEC source: 0001736502-25-000005 · wk-form4_1763071283.xml · nonDerivative · entry 4

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,272

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 16:53 UTC SaleCommon Shares 2,750 $45.65 $125,537.50
Disclosure

SEC source: 0001855053-25-000004 · wk-form4_1763070834.xml · nonDerivative · entry 1

Franklin Tamara · CIK 0001855053 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,236

Read SEC document
November 12, 2025 Filed Nov 13, 2025 22:01 UTC
White HeatherSVP & Chief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,351 $0.00 Strike: $27.70 $0.00
Disclosure

SEC source: 0001736502-25-000005 · wk-form4_1763071283.xml · derivative · entry 6

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,703

Underlying: Common Shares · 4,351 shares

Expires 2029-01-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested 50% on January 10, 2022 and 50% on January 10, 2024.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 22:01 UTC
White HeatherSVP & Chief Legal Officer
SaleCommon Shares 4,351 $45.74 $199,014.74
Disclosure

SEC source: 0001736502-25-000005 · wk-form4_1763071283.xml · nonDerivative · entry 3

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,569

Read SEC document
November 12, 2025 Filed Nov 13, 2025 22:01 UTC
White HeatherSVP & Chief Legal Officer
Exercise / conversionCommon Shares 4,351 $27.70 $120,522.70
Disclosure

SEC source: 0001736502-25-000005 · wk-form4_1763071283.xml · nonDerivative · entry 2

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:57 UTC
Dewan SameerSenior Vice President
SaleCommon Shares 26,531 $44.70 $1,185,935.70
Disclosure

SEC source: 0002015050-25-000006 · wk-form4_1763071032.xml · nonDerivative · entry 1

Dewan Sameer · CIK 0002015050 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,617

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.70 to $44.7305. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 22:01 UTC
White HeatherSVP & Chief Legal Officer
SaleCommon Shares 1,039 $44.02 $45,736.78
Disclosure

SEC source: 0001736502-25-000005 · wk-form4_1763071283.xml · nonDerivative · entry 1

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,569

F1 · balance_after: Includes 30 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 560 shares under the ESPP.

Read SEC document
October 10, 2025 Filed Oct 14, 2025 20:02 UTC
Radesca Anthony J.Chief Accounting Officer
GrantCommon Shares 20,066 $0.00 $0.00
Disclosure

SEC source: 0001676073-25-000008 · wk-form4_1760472169.xml · nonDerivative · entry 1

Radesca Anthony J. · CIK 0001676073 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,066

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of April 30, 2027, July 31, 2027 and October 31, 2027, subject to the reporting person's continued service through each vesting date.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 16:36 UTC
Mehta PiyushSenior Vice President and CHRO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $31.50 $0.00
Disclosure

SEC source: 0001408238-25-000004 · wk-form4_1757968564.xml · derivative · entry 4

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 50,000 shares

Expires 2028-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested 50% on April 2, 2021 and the remainder on April 2, 2023.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 16:36 UTC
Mehta PiyushSenior Vice President and CHRO
SaleCommon Shares 26,902 $42.58 $1,145,487.16
Disclosure

SEC source: 0001408238-25-000004 · wk-form4_1757968564.xml · nonDerivative · entry 3

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,880

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.70. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 16:36 UTC
Mehta PiyushSenior Vice President and CHRO
SaleCommon Shares 50,000 $42.58 $2,129,000.00
Disclosure

SEC source: 0001408238-25-000004 · wk-form4_1757968564.xml · nonDerivative · entry 2

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,782

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 16:36 UTC
Mehta PiyushSenior Vice President and CHRO
Exercise / conversionCommon Shares 50,000 $31.50 $1,575,000.00
Disclosure

SEC source: 0001408238-25-000004 · wk-form4_1757968564.xml · nonDerivative · entry 1

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 284 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 10,222 shares under the ESPP.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:10 UTC
Kalra BalkrishanDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $27.65 $0.00
Disclosure

SEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · derivative · entry 4

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,800

Underlying: Common Shares · 40,000 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:10 UTC
Kalra BalkrishanDirector · President and CEO
SaleCommon Shares 40,000 $43.35 $1,734,000.00
Disclosure

SEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · nonDerivative · entry 3

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,246

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.29 to $43.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:10 UTC
Kalra BalkrishanDirector · President and CEO
Exercise / conversionCommon Shares 40,000 $27.65 $1,106,000.00
Disclosure

SEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · nonDerivative · entry 2

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 20:10 UTC
Kalra BalkrishanDirector · President and CEO
SaleCommon Shares 15,000 $43.39 $650,850.00
Disclosure

SEC source: 0001768217-25-000004 · wk-form4_1757967049.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,246

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.39 to $43.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 16:06 UTC
Klunk Donald JChief Accounting Officer
SaleCommon Shares 2,695 $44.77 $120,655.15
Disclosure

SEC source: 0001986716-25-000003 · wk-form4_1757016408.xml · nonDerivative · entry 2

Klunk Donald J · CIK 0001986716 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,440

Read SEC document
September 02, 2025 Filed Sep 4, 2025 16:06 UTC
Klunk Donald JChief Accounting Officer
Tax withholdingCommon Shares 1,468 $45.34 $66,559.12
Disclosure

SEC source: 0001986716-25-000003 · wk-form4_1757016408.xml · nonDerivative · entry 1

Klunk Donald J · CIK 0001986716 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,135

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.

F2 · balance_after: Includes 252 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 673 shares under the ESPP.

Read SEC document
August 28, 2025 Filed Aug 29, 2025 20:06 UTC
Dewan SameerSenior Vice President
SaleCommon Shares 20,078 $45.00 $903,510.00
Disclosure

SEC source: 0002015050-25-000003 · wk-form4_1756497961.xml · nonDerivative · entry 1

Dewan Sameer · CIK 0002015050 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,148

Read SEC document
August 22, 2025 Filed Aug 25, 2025 20:06 UTC
Nanduru AnilSenior Vice President
SaleCommon Shares 9,744 $45.50 $443,352.00
Disclosure

SEC source: 0002014966-25-000003 · wk-form4_1756152365.xml · nonDerivative · entry 2

Nanduru Anil · CIK 0002014966 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,846

F1 · balance_after: Includes 237 shares acquired through dividend reinvestment since the reporting person's Form 4 filed on March 13, 2025.

Read SEC document
August 22, 2025 Filed Aug 25, 2025 16:05 UTC
Vashisht RijuSenior Vice President
SaleCommon Shares 7,931 $45.57 $361,415.67
Disclosure

SEC source: 0002014981-25-000003 · wk-form4_1756152347.xml · nonDerivative · entry 2

Vashisht Riju · CIK 0002014981 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,270

F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.56 to $45.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2 · balance_after: Includes 160 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 4,154 shares under the ESPP.

Read SEC document
August 22, 2025 Filed Aug 25, 2025 16:05 UTC
Vashisht RijuSenior Vice President
SaleCommon Shares 17,608 $45.61 $803,100.88
Disclosure

SEC source: 0002014981-25-000003 · wk-form4_1756152347.xml · nonDerivative · entry 1

Vashisht Riju · CIK 0002014981 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,201

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.60 to $45.66. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2 · balance_after: Includes 160 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 4,154 shares under the ESPP.

Read SEC document
August 21, 2025 Filed Aug 25, 2025 20:06 UTC
Nanduru AnilSenior Vice President
SaleCommon Shares 18,218 $44.50 $810,701.00
Disclosure

SEC source: 0002014966-25-000003 · wk-form4_1756152365.xml · nonDerivative · entry 1

Nanduru Anil · CIK 0002014966 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,590

F1 · balance_after: Includes 237 shares acquired through dividend reinvestment since the reporting person's Form 4 filed on March 13, 2025.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 20:06 UTC GrantCommon Shares 2,020 $0.00 $0.00
Disclosure

SEC source: 0002015287-25-000005 · wk-form4_1755115578.xml · nonDerivative · entry 1

Subaiya Thimaya K. · CIK 0002015287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,020

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 20:11 UTC SaleCommon Shares 2,326 $43.17 $100,413.42
Disclosure

SEC source: 0001398659-25-000100 · wk-form4_1755115864.xml · nonDerivative · entry 1

Lindstrom Carol · CIK 0001677400 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,185

Read SEC document
July 01, 2025 Filed Jul 3, 2025 20:12 UTC GrantCommon Shares 2,334 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000090 · wk-form4_1751573555.xml · nonDerivative · entry 1

Hinshaw John M · CIK 0001534787 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,334

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 20:05 UTC GrantCommon Shares 1,988 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000086 · wk-form4_1751486749.xml · nonDerivative · entry 1

Gangestad Nicholas C · CIK 0001515709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,813

Read SEC document
May 22, 2025 Filed May 27, 2025 17:00 UTC GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000077 · wk-form4_1748379648.xml · nonDerivative · entry 1

Franklin Tamara · CIK 0001855053 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,986

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 21:00 UTC GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000074 · wk-form4_1748379608.xml · nonDerivative · entry 1

STEVENS BRIAN MARK · CIK 0001778160 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,098

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 17:00 UTC
Agrawal AjayDirector
GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000075 · wk-form4_1748379622.xml · nonDerivative · entry 1

Agrawal Ajay · CIK 0001765311 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,972

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 20:59 UTC GrantCommon Shares 7,582 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000071 · wk-form4_1748379570.xml · nonDerivative · entry 1

Madden James C. · CIK 0001408228 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,068

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 20:59 UTC GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000073 · wk-form4_1748379593.xml · nonDerivative · entry 1

Morken CeCelia · CIK 0001367198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,760

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 21:01 UTC GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000079 · wk-form4_1748379672.xml · nonDerivative · entry 1

Conigliaro Laura · CIK 0001528935 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,816

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 21:01 UTC GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000078 · wk-form4_1748379660.xml · nonDerivative · entry 1

Gangestad Nicholas C · CIK 0001515709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,825

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 21:00 UTC GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000076 · wk-form4_1748379633.xml · nonDerivative · entry 1

Lindstrom Carol · CIK 0001677400 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,511

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 20:59 UTC
Verdi Mark ADirector
GrantCommon Shares 4,825 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000072 · wk-form4_1748379581.xml · nonDerivative · entry 1

Verdi Mark A · CIK 0001560520 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,005

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.

Read SEC document
May 13, 2025 Filed May 14, 2025 20:19 UTC PurchaseCommon Shares 2,000 $43.97 $87,940.00
Disclosure

SEC source: 0001398659-25-000061 · wk-form4_1747253955.xml · nonDerivative · entry 1

Gangestad Nicholas C · CIK 0001515709 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
March 13, 2025 Filed Mar 14, 2025 20:04 UTC
Kalra BalkrishanDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 13,600 $0.00 Strike: $27.65 $0.00
Disclosure

SEC source: 0001398659-25-000053 · wk-form4_1741982638.xml · derivative · entry 3

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,800

Underlying: Common Shares · 13,600 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.

Read SEC document
March 13, 2025 Filed Mar 14, 2025 20:04 UTC
Kalra BalkrishanDirector · President and CEO
SaleCommon Shares 13,600 $48.89 $664,904.00
Disclosure

SEC source: 0001398659-25-000053 · wk-form4_1741982638.xml · nonDerivative · entry 2

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 310,246

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $48.70 to $49.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 13, 2025 Filed Mar 14, 2025 20:04 UTC
Kalra BalkrishanDirector · President and CEO
Exercise / conversionCommon Shares 13,600 $27.65 $376,040.00
Disclosure

SEC source: 0001398659-25-000053 · wk-form4_1741982638.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 323,846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:10 UTC
Nanduru AnilSenior Vice President
GrantCommon Shares 14,910 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000050 · wk-form4_1741896614.xml · nonDerivative · entry 1

Nanduru Anil · CIK 0002014966 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,571

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 16:09 UTC
Vashisht RijuSenior Vice President
GrantCommon Shares 14,839 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000045 · wk-form4_1741896560.xml · nonDerivative · entry 1

Vashisht Riju · CIK 0002014981 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,649

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date.

F2 · balance_after: Includes 357 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 14, 2025. The reporting person currently holds a total of 3,994 shares under the ESPP.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:10 UTC
Dewan SameerSenior Vice President
GrantCommon Shares 10,759 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000051 · wk-form4_1741896625.xml · nonDerivative · entry 1

Dewan Sameer · CIK 0002015050 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,226

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 16:09 UTC
Klunk Donald JChief Accounting Officer
GrantCommon Shares 2,518 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000046 · wk-form4_1741896572.xml · nonDerivative · entry 1

Klunk Donald J · CIK 0001986716 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,351

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date.

F2 · balance_after: Includes 56 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on February 13, 2025. The reporting person currently holds a total of 421 shares under the ESPP.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 16:09 UTC
Mehta PiyushSenior Vice President and CHRO
GrantCommon Shares 17,711 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000048 · wk-form4_1741896592.xml · nonDerivative · entry 1

Mehta Piyush · CIK 0001408238 · Senior Vice President and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,498

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date.

F2 · balance_after: Includes 116 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 17, 2025. The reporting person currently holds a total of 9,938 shares under the ESPP.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:10 UTC
Kalra BalkrishanDirector · President and CEO
GrantCommon Shares 78,782 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000049 · wk-form4_1741896603.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,246

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date.

F2 · balance_after: Includes 521 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on January 14, 2025. The reporting person currently holds a total of 8,375 shares under the ESPP.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:09 UTC
White HeatherSVP & Chief Legal Officer
GrantCommon Shares 7,958 $0.00 $0.00
Disclosure

SEC source: 0001398659-25-000047 · wk-form4_1741896583.xml · nonDerivative · entry 1

White Heather · CIK 0001736502 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,578

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2026, January 10, 2027 and January 10, 2028, subject to the reporting person's continued service through each vesting date.

F2 · balance_after: Includes 498 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on February 18, 2025. The reporting person currently holds a total of 1,569 shares under the ESPP.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.